spacer
home > ict > winter 2009 > the latin beat
PUBLICATIONS
International Clinical Trials

The Latin Beat

 

The experience of running clinical trials in Latin America has improved markedly in recent years in line with the breadth of resources and expertise now available in the region. Graciela Rácaro at PAREXEL International examines the pace of evolution during the last decade

Latin America has evolved as an important area for clinical research, and the industry has shown increasing interest in the emerging region that will serve as a potential new end market for biopharmaceutical products. While clinical trial sponsors used to consider Latin America primarily in large studies or for clinical trials that could not achieve the required patient recruitment on time in ‘traditional’ research countries, more recently they have included the region from the beginning when planning their product development programmes.

Latin America has evolved as an important area for clinical research, and the industry has shown increasing interest in the emerging region that will serve as a potential new end market for biopharmaceutical products. While clinical trial sponsors used to consider Latin America primarily in large studies or for clinical trials that could not achieve the required patient recruitment on time in ‘traditional’ research countries, more recently they have included the region from the beginning when planning their product development programmes.

The growth of clinical trials in Latin America (which is linked to FDA/EMEA acceptance of foreign research data, a huge pool of potential trial patients, and the globalisation of clinical research) should be assessed not only in terms of the number of studies conducted in the region, but also through the experience gained during the last few years.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

 You must be a member of the site to make a comment.
spacer

Graciela Rácaro is Senior Director, Clinical Operations, Latin America at PAREXEL International. She is responsible for all clinical and regulatory activities in Latin America. Graciela specialises in drug development and non-clinical and clinical research. Her background includes serving as clinical lead and project manager for Latin American projects as well as global programmes. Prior to joining PAREXEL, Graciela held a clinical management position at Serono International, and previously worked at the clinical research organisation EDYABE and pharmaceutical company Laboratorio Gador, SA. Graciela holds BCh and Pharm degrees from the College of Pharmacy and Biochemistry at the University of Buenos Aires, and completed her Masters in Clinical Research and Clinical Trials Monitoring at the University Maimónides College of Medicine in Buenos Aires. Email: graciela.racaro@parexel.com

 

spacer
Graciela Rácaro
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Significant improvement in overall survival with ERLEADA®▼ (apalutamide) for patients with non-metastatic castration-resistant prostate cancer

BEERSE, BELGIUM, May 14, 2020 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced results from the final analysis of the pivotal Phase 3 SPARTAN study demonstrating ERLEADA®▼ (apalutamide) in combination with androgen deprivation therapy (ADT) significantly improved overall survival (OS), compared to ADT alone, in patients with non-metastatic castration-resistant prostate cancer (nmCRPC) who were at high risk of developing metastases.1 Results will be presented at the American Society of Clinical Oncology (ASCO) Virtual Scientific Programme (Abstract #5516) beginning on Friday 29th May.
More info >>

White Papers

What You Need To Know About Thermal Shipping Technologies

Temptime Corporation

This paper presents highlights from a thermal performance study conducted by Modality Solutions LLC. The study examined the performance of five shipping technologies commonly used by specialty pharmacies to transport high-value refrigerated specialty medicines against an industry accepted temperature profile standard.
More info >>

 
Industry Events

Clinical Operations in Oncology Trials West Coast

17-18 November 2020, Hilton San Francisco Airport Bayfront

Clinical Operations in Oncology Trials West Coast will be returning this April for another 2 day event full of thought-provoking presentations, discussions and roundtables. This years' conference highlights include the high-level, interactive immuno-oncology discussion panel where specialists from Shasta Bio Ventures, Abbvie and BeiGene shared their top tips on how to run successful and impactful immuno-oncology studies.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement